Long
Molecular Coin (MOF) 80% or 120% Easy & Fast!
Molecular Coin (MOFBTC) printed the Cup & Handle bullish chart pattern and has already gone up.
Today we see prices growing after closing above EMA100, with plenty of room left for additional gains.
Our first target is set at 0.618 Fib. extension or EMA200 at 0.00001300 satoshis, for a nice 80% in potential profits.
The next target is set at 120% of profits right above this one at 0.00001577.
This is not financial advice.
Enjoy the trade.
Namaste.
Today we see prices growing after closing above EMA100, with plenty of room left for additional gains.
Our first target is set at 0.618 Fib. extension or EMA200 at 0.00001300 satoshis, for a nice 80% in potential profits.
The next target is set at 120% of profits right above this one at 0.00001577.
This is not financial advice.
Enjoy the trade.
Namaste.
Nota
Extreme bullishness!Nota
We keep on growing.I am aiming above the 80% marked on the chart :D
Enjoy.
🚨 Get the FULL (6-in-1) PREMIUM PACKAGE
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
Pubblicazioni correlate
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.
🚨 Get the FULL (6-in-1) PREMIUM PACKAGE
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
Pubblicazioni correlate
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.